Development Level

Tbio 6 | 10,625
Tchem 6 | 1,890
Tclin 5 | 602

IMPC Term

abnormal tooth morphology 1 | 24
decreased circulating glucose ... 1 | 121
decreased circulating serum al... 1 | 79
decreased circulating sodium l... 1 | 18
increased circulating HDL chol... 1 | 63
increased circulating LDL chol... 1 | 15
increased circulating alkaline... 1 | 119
increased circulating bilirubi... 1 | 16
increased circulating choleste... 1 | 53
increased circulating free fat... 1 | 17
increased circulating triglyce... 1 | 24
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 25
tremors 1 | 34

Disease

Cancer 11 | 2,346
osteosarcoma 11 | 7,933
ovarian cancer 11 | 8,492
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,289
psoriasis 9 | 6,685
invasive ductal carcinoma 8 | 2,950
glioblastoma 7 | 5,572
non-small cell lung cancer 7 | 2,798
ulcerative colitis 7 | 2,087
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,988
lung adenocarcinoma 6 | 2,714
tuberculosis 6 | 1,563
Breast cancer 5 | 3,099
Coronary artery disease 5 | 240
colon cancer 5 | 1,475
diabetes mellitus 5 | 1,663
group 3 medulloblastoma 5 | 2,254
lung cancer 5 | 4,473
lung carcinoma 5 | 2,844
malignant mesothelioma 5 | 3,163
pilocytic astrocytoma 5 | 3,086
Arthritis 4 | 248
Cerebrovascular disease 4 | 231
Hypertension 4 | 293
IGA Glomerulonephritis 4 | 454
Rheumatoid Arthritis 4 | 1,171
adrenocortical carcinoma 4 | 1,427
atypical teratoid / rhabdoid tumor 4 | 4,369
cystic fibrosis 4 | 1,670
interstitial cystitis 4 | 2,299
juvenile dermatomyositis 4 | 1,189
oligodendroglioma 4 | 2,849
pancreatic cancer 4 | 2,300
pediatric high grade glioma 4 | 2,712
subependymal giant cell astrocytoma 4 | 2,287
Allergic rhinitis 3 | 92
Asthma, Aspirin-Induced 3 | 13
Atherosclerosis 3 | 275
Atopic dermatitis 3 | 944
Cervical ripening procedure 3 | 9
Common cold 3 | 63
Down syndrome 3 | 548
Duchenne muscular dystrophy 3 | 602
Endometriosis 3 | 535
Glanzmann's thrombasthenia 3 | 21
Heart disease 3 | 279
Hydatidiform mole, benign 3 | 9
Incomplete miscarriage 3 | 10
Induction of labor 3 | 10
Malaria 3 | 140
Obesity 3 | 616
Physiological Sexual Disorders 3 | 4
Pregnancy with abortive outcome 3 | 12
Thrombocytopenia 3 | 105
Vascular disease 3 | 281
acute quadriplegic myopathy 3 | 1,157
astrocytic glioma 3 | 2,241
dermatomyositis 3 | 967
ductal carcinoma in situ 3 | 1,745
medulloblastoma, large-cell 3 | 6,234
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
pituitary cancer 3 | 1,972
posterior fossa group B ependymoma 3 | 1,530
uncontrolled asthma 3 | 67
Adenoma 2 | 165
Autoimmune thrombocytopenic purpura 2 | 14
Cerebrovascular accident 2 | 44
Coronary heart disease 2 | 59
Cough 2 | 21
Crohn's disease 2 | 304
Hyperalgesia 2 | 71
Hypertensive disease 2 | 193
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Juvenile arthritis 2 | 124
Kidney disease 2 | 397
Liver disease 2 | 219
Multiple Sclerosis 2 | 498
Nerve Degeneration 2 | 73
Purpura 2 | 17
Toxic encephalopathy 2 | 131
active Crohn's disease 2 | 918
aldosterone-producing adenoma 2 | 664
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
breast carcinoma 2 | 1,614
chronic lymphosyte leukemia 2 | 232
cutaneous lupus erythematosus 2 | 1,056
ependymoma 2 | 2,514
esophageal adenocarcinoma 2 | 737
gastric carcinoma 2 | 832
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
hereditary spastic paraplegia 2 | 313
mucosa-associated lymphoid tissue lymphoma 2 | 480
nasopharyngeal carcinoma 2 | 1,056
nephrosclerosis 2 | 329
pancreatic carcinoma 2 | 567
posterior fossa group A ependymoma 2 | 1,511
primary pancreatic ductal adenocarcinoma 2 | 1,271
pulmonary arterial hypertension 2 | 36

Tissue

Blood and immune system 17 | 17,995
Cardiovascular System 17 | 17,958
Digestive Tract 17 | 18,473
Endocrine System 17 | 18,512
Female tissues 17 | 18,647
Liver and Pancreas 17 | 18,136
Nervous System 17 | 18,561
Respiratory system 17 | 17,484
Skin and soft tissues 17 | 18,115
Urinary Tract 17 | 18,444
Male tissues 16 | 17,969

Target Family

Non-IDG 7 | 11,969
GPCR 5 | 408
Enzyme 3 | 4,146
Transcription Factor 2 | 1,400

Grant Application

5P01HL062250-09 17 | 17
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Platelet glycoprotein 4 CD36 Tchem Non-IDG -2.61942 361.5 892
Prostaglandin D2 receptor 2 PTGDR2 Tchem GPCR -2.35437 249.5 398
Apolipoprotein E APOE Tbio Non-IDG -4.15802 15380.4 788
Cytochrome c oxidase subunit 2 MT-CO2 Tchem Enzyme -2.94466 857.2 116
Prostaglandin E synthase PTGES Tchem Enzyme -3.02917 1099.8 145
Class E basic helix-loop-helix protein 22 BHLHE22 Tbio Transcription Factor -2.99110 859.4 92
Prostaglandin E2 receptor EP4 subtype PTGER4 Tclin GPCR -2.95863 922.9 216
Integrin alpha-IIb ITGA2B Tclin Non-IDG -3.51144 3249.0 927
Prostaglandin E2 receptor EP2 subtype PTGER2 Tclin GPCR -1.21342 15.1 372
Prostacyclin receptor PTGIR Tclin GPCR -2.98778 898.0 168